Pancreatic Cancer Research

ResearcherUniversity of North Carolina at Chapel HillNo recent work listed

Sonja M. Wörmann

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5887-6935; OpenAlex author ID A5053673252. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
59
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 1 paper

Papers 9

  1. Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/gutjnl-2021-325564↗
  2. APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis. Co-author DOI 10.1038/s43018-021-00268-8↗
  3. Bcl3 Couples Cancer Stem Cell Enrichment With Pancreatic Cancer Molecular Subtypes. First author DOI 10.1053/j.gastro.2021.03.051↗
  4. Distinct Pathogenesis of Pancreatic Cancer Microvesicle-Associated Venous Thrombosis Identifies New Antithrombotic Targets In Vivo. Co-author DOI 10.1161/atvbaha.117.310262↗
  5. Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts. Co-author DOI 10.1007/s40266-017-0453-y↗
  6. Activated Schwann cells in pancreatic cancer are linked to analgesia via suppression of spinal astroglia and microglia. Co-author DOI 10.1136/gutjnl-2015-309784↗
  7. Basophil Recruitment into Tumor-Draining Lymph Nodes Correlates with Th2 Inflammation and Reduced Survival in Pancreatic Cancer Patients. First author DOI 10.1158/0008-5472.can-15-1801-t↗
  8. The immune network in pancreatic cancer development and progression. Co-author DOI 10.1038/onc.2013.257↗
  9. Risk factors and therapeutic targets in pancreatic cancer. Co-author DOI 10.3389/fonc.2013.00282↗

Closest collaborators

The 25 strongest of 59 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hana Algül · 8 shared papers, 2013–2023 · strength 0.60
  2. Kıvanç Görgülü · 3 shared papers, 2017–2023 · strength 0.31
  3. Derya Kabacaoğlu · 2 shared papers, 2021–2023 · strength 0.21
  4. Sonia Alcalá · 2 shared papers, 2021–2023 · strength 0.21
  5. Bruno Sáinz · 2 shared papers, 2021–2023 · strength 0.21
  6. Dietrich Alexander Ruess · 2 shared papers, 2017–2021 · strength 0.19
  7. Marina Lesina · 2 shared papers, 2014–2021 · strength 0.15
  8. İhsan Ekin Demir · 2 shared papers, 2016–2021 · strength 0.14
  9. Guralp Onur Ceyhan · 2 shared papers, 2016–2021 · strength 0.14
  10. Marta Alonso‐Nocelo · 1 shared paper, 2023 · strength 0.12
  11. Patricia Sancho · 1 shared paper, 2023 · strength 0.12
  12. Mert Erkan · 1 shared paper, 2023 · strength 0.12
  13. Sara Maria David Trabulo · 1 shared paper, 2023 · strength 0.12
  14. Sandra Valle · 1 shared paper, 2023 · strength 0.12
  15. Patrick Christian Hermann · 1 shared paper, 2023 · strength 0.12
  16. Juan Carlos López-Gil · 1 shared paper, 2023 · strength 0.12
  17. Alfredo Carrato · 1 shared paper, 2023 · strength 0.12
  18. Christopher Heeschen · 1 shared paper, 2023 · strength 0.12
  19. Paola Martinelli · 1 shared paper, 2023 · strength 0.12
  20. Julie Earl · 1 shared paper, 2023 · strength 0.12
  21. Melena D. Bellin · 1 shared paper, 2021 · strength 0.09
  22. Matthew H. G. Katz · 1 shared paper, 2021 · strength 0.09
  23. Robert W. Cowan · 1 shared paper, 2021 · strength 0.09
  24. Ravikanth Maddipati · 1 shared paper, 2021 · strength 0.09
  25. Fredrik I. Thege · 1 shared paper, 2021 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.